Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES)

NCT03126227 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

506

Enrollment

INDUSTRY

Sponsor class

Conditions

Peanut Allergy

Interventions

BIOLOGICAL: AR101
BIOLOGICAL: Placebo

Sponsor

Aimmune Therapeutics, Inc.